HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.2
  1. Home
  2. /Reaction

Diisopropylethylamine → {(1S,3R)-3-ethoxy-1-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-ylcarbamoyl]-butyl}-carbamic acid t-butyl ester

HRID 19038
Print

Reaction equation

HRID 19038 reaction equation
[C:1]([O:5][C:6]([NH:8][C@@H:9]([CH2:13][C@H:14]([O:16][CH2:17][CH3:18])[CH3:15])[C:10]([OH:12])=O)=[O:7])([CH3:4])([CH3:3])[CH3:2].Cl.[OH:20][C@@H:21]([CH2:51]O)[CH2:22][N:23]1[CH:27]=[CH:26][C:25]([NH:28]C(=O)[C@@H](N2CC(OC3C=CC=C(Cl)C=3Cl)=CC2=O)CC(C)C)=[N:24]1.F[P-](F)(F)(F)(F)F.N1(O[P+](N(C)C)(N(C)C)N(C)C)C2C=CC=C[C:63]=2N=N1.C(N(CC)C(C)C)(C)C>CN(C)C=O>[C:1]([O:5][C:6](=[O:7])[NH:8][C@H:9]([C:10](=[O:12])[NH:28][C:25]1[CH:26]=[CH:27][N:23]([CH2:22][C:21]([OH:20])([CH3:51])[CH3:63])[N:24]=1)[CH2:13][C@H:14]([O:16][CH2:17][CH3:18])[CH3:15])([CH3:2])([CH3:3])[CH3:4]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

6

Reactant 4

HCID 81531DiisopropylethylamineHCID 151348Benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphateHCID 66899094HMS5552 HClHCID 86635229(2S,4R)-2-t-butoxycarbonylamino-4-ethoxy-pentanoic acid

Product 1

HCID 66899703{(1S,3R)-3-ethoxy-1-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-ylcarbamoyl]-butyl}-carbamic acid t-butyl ester
Yield 73.8%

Reagents, catalysts & solvents 1

HCID 6228DimethylformamideSolvent

Procedure

(2S,4R)-2-t-butoxycarbonylamino-4-ethoxy-pentanoic acid (273 mg, 1.04 mmol) was mixed with 1-(3-amino-pyrazol-1-yl)-2-methyl-propan-2-ol (prepared in U.S. Pat. Appl. US2008021032 Example 80, 194.6 mg, 1.25 mmol) in N,N-dimethylformamide (10 mL). benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (695 mg, 1.57 mmol) and N,N-diisopropylethylamine (0.4 mL) was added at 0° C. The mixture was stirred at room temperature overnight. Solvents were evaporated and the residue was extracted with ethyl acetate and saturated sodium chloride solution. Solvents were evaporated and the crude material was purified by flash column chromatography (silica gel, 10-80% ethyl acetate/hexanes) to afford {(1S,3R)-3-ethoxy-1-[1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-ylcarbamoyl]-butyl}-carbamic acid t-butyl ester (306 mg, 73%) as a white solid: LR-ES-MS m/z calculated for C19H34N4O5 [M]+ 398, observed [M+H]+ 399; 1H NMR (300 MHz, CDCl3, plus drops of CD3OD) δ ppm 1.08-1.15 (m, 12H), 1.37 (s, 9H), 1.72-1.94 (m, 2H), 3.35-3.60 (m, 3H), 3.89 (s, 2H), 4.20 (m, 1H), 6.48 (br. s., 1H).

Workup

  1. customSolvents were evaporated
  2. extractionthe residue was extracted with ethyl acetate and saturated sodium chloride solution
  3. customSolvents were evaporated
  4. customthe crude material was purified by flash column chromatography (silica gel, 10-80% ethyl acetate/hexanes)

Sources & evidence

ORD record
ord-eb49e35cc30b48fe9f55bd625413ca99
Source dataset
uspto-grants-2010_06
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US07741327B2

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes